Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,071.2
6.7 (0.22%)

 

  • STI Straits Times Index
    3,071.2
    6.7 (0.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,548.5
    -6.8 (-0.43%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,920.8
    252.9 (1.03%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,614.0
    6.9 (0.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,500.0
    176.7 (0.58%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,133.2
    23.3 (0.38%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,452.5M
  • Value: 2,581.7M
  • Rise: 161
  • Fall: 177
  • Unch: 416

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.073+0.013
ESR-REIT0.475-0.010
OUE Com Reit0.445-
Sembcorp Marine0.084+0.001
StarhillGbl Reit0.630-0.005
ARA LOGOS Log Tr0.935+0.010
GSS Energy0.077+0.005
Lippo Malls Tr0.054+0.003
Singtel2.430+0.030
CapLand IntCom T2.000-0.020

World Indices

World Indices
Name Last Change
Nasdaq 15,044.0 -138.0
HSI 24,920.8 +252.9
HSCEI 8,940.5 +134.7
Jakarta 6,133.2 +23.3
Nikkei 225 30,500.0 +176.7
SSE Comp 3,614.0 +6.9
Shanghai A 3,787.7 +7.3
Shanghai B 273.1 -1.8
KOSPI 3,140.5 +10.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

HARTA HARTALEGA HOLDINGS BHD
Quotes 15 Minutes Delayed. Updated at 17 Sep 2021 16:59
Last (MYR): 6.400 Change: +0.150 High: 6.580 Remarks: s
Remarks legend:
RemarksDescriptionRemarksDescription
IOrder entry forbiddenAOrder entry authorized
GFrozenSSuspended
RReservedsShort selling available
[x]Exclude dividend[c] Cum dividend
Change (%): +2.40 Low: 6.210
Open 6.320 Yesterday's Close 6.250
Buy Price 6.380 Sell Price 6.400
Buy Volume ('00) 41 Sell Volume ('00) 356
Cumulative Volume ('00) 167,056 Cumulative Value 106,739,060
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a 0.84434 Trailing EPS (MYR) e 1.44119 NAV (MYR) b 1.9109
PE a 7.580 Trailing PE f 4.441 Price / NAV b 3.3492
Dividend (MYR) d 0.511013 Cash In Hand (MYR) g 0.9964 Issued & Paid-up Shares c 3,417,462,000
Dividend Yield (%) d 7.985 Price / Cash In Hand g 6.423 Treasury Shares h 10,145,000
Beta - 75 Daysi 1.463 R-Squared - 75 Days(%)i 17.79 Market Cap (M) 21,871.757
Beta - 500 Daysi 1.036 R-Squared - 500 Days (%)i 10.06 Enterprise Value (M) 18,819.108
Piotroski F Score 8 Exchange Code 5168 Par Value ( $ ) n.a.
52 Weeks Volatility (%) 45.72 6-Month VWAP 8.430 Free Float (%) 34.2
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Medical Specialties
Index Components BM HEALTH CARE / FTSE Bursa Malaysia EMAS Index / FTSE Bursa Malaysia EMAS Shariah Index / FTSE Bursa Malaysia Hijrah Shariah Index / FTSE Bursa Malaysia KLCI Index / FTSE Bursa Malaysia Top 100 Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 18 Jun 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 18 Jun 2021.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference HARTA Bursa 21,871.757 7.580 4.441 3.3492 7.985
Industry HEALTH CARE EQUIPMENT & SERVICES Bursa 7,653.875 6.353 2.972 2.6940 5.173
Medical Specialties Bursa 8,962.916 6.367 3.107 2.9155 5.035
Index BM HEALTH CARE Bursa 7,702.835 12.876 5.845 2.6254 2.798
FTSE Bursa Malaysia EMAS Index Bursa 5,255.354 31.747 19.585 1.3037 2.625
FTSE Bursa Malaysia EMAS Shariah Index Bursa 4,566.944 30.666 16.418 1.5166 2.424
FTSE Bursa Malaysia Hijrah Shariah Index Bursa 17,566.698 20.703 14.567 1.7645 2.842
FTSE Bursa Malaysia KLCI Index Bursa 34,389.822 24.975 16.041 1.6663 2.682
FTSE Bursa Malaysia Top 100 Index Bursa 14,035.015 29.588 18.203 1.5537 2.451
Local Peer TOPGLOV Bursa 24,494.781 13.976 2.857 3.5619 3.925
Local Peer SUPERMX Bursa 6,753.509 1.771 1.771 1.4205 -
Local Peer RGTBHD Bursa 275.712 27.538 27.533 2.6966 -
Local Peer ADVENTA Bursa 207.789 - - 3.3597 -
Local Peer LKL Bursa 173.950 - - 0.9058 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 234,792.459 36.830 27.314 6.3709 0.149
Global Peer DANAHER CORP NYSE 231,681.967 66.006 66.006 5.8671 0.221
Global Peer ABBOTT LABORATORIES NYSE 224,775.848 50.252 35.420 6.6502 1.206
Global Peer MEDTRONIC PLC NYSE 174,551.557 48.406 44.953 3.3903 1.865
Global Peer INTUITIVE SURGICAL INC NASDAQ 123,425.795 116.374 76.067 11.3888 -
Global Peer STRYKER CORP NYSE 102,958.521 64.389 49.428 7.4500 0.860
Global Peer BECTON DICKINSON & CO NYSE 75,229.420 98.083 40.337 3.1173 1.234
Global Peer EDWARDS LIFESCIENCES CORP NYSE 74,437.830 90.403 50.901 14.5010 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,176.224 - 134.992 3.9629 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 56,839.293 32.006 81.379 16.7944 -
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALCON AG (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), MICROPORT (HKEx), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), WEIGAO GROUP (HKEx), TANDEM DIABETES CARE INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), ANGELALIGN (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), STAAR SURGICAL CO (NASDAQ), QUIDEL CORP (NASDAQ), Top Glove (SGX), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), INMODE LTD (NASDAQ), ICU MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), LIVANOVA PLC (NASDAQ), EBOS GROUP (ASX), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), HAEMONETICS CORP (NYSE), CAREDX INC (NASDAQ), ATRICURE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), GLAUKOS CORPORATION (NYSE), VENUS MEDTECH-B (HKEx), VERICEL CORP (NASDAQ), LIFETECH SCI (HKEx), BUTTERFLY NETWORK INC (NYSE), CARDIOFLOW-B (HKEx), SILK ROAD MEDICAL INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), PEIJIA-B (HKEx), ZYLOXTB-B (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), KANGJI MEDICAL (HKEx), MESA LABORATORIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), TREACE MED CONCEPTS INC (NASDAQ), AK MEDICAL (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), NANOSONICS LIMITED (ASX), ORTHOPEDIATRICS CORP (NASDAQ), ATRION CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), INOGEN INC (NASDAQ), DERMTECH INC (NASDAQ), VIEWRAY INC (NASDAQ), 908 DEVICES INC (NASDAQ), MODERN DENTAL (HKEx), ANGIODYNAMICS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), CRYOLIFE INC (NYSE), CIRC (HKEx), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), EARGO INC (NASDAQ), CUTERA INC (NASDAQ), SISRAM MED (HKEx), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SI BONE INC (NASDAQ), BIOVENTUS INC (NASDAQ), NYXOAH SA (NASDAQ), CHUNLI MEDICAL (HKEx), INTERCURE LTD (NASDAQ), VAPOTHERM INC (NYSE), KDL MEDICAL (HKEx), PAVMED INC (NASDAQ), AXOGEN INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), ACOTEC-B (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), SEASPINE HOLDINGS CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), HEARTCARE-B (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVITA MEDICAL INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), SOLITON INC (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), CLEARPOINT NEURO INC (NASDAQ), ZYNEX INC (NASDAQ), BASECARE-B (HKEx), STEREOTAXIS INC (NYSE American), MISONIX INC (NASDAQ), NEUROPACE INC (NASDAQ), IRADIMED CORP (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), CYTOSORBENTS CORP (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), ACCELERATE DIAGNOSTICS INC (NASDAQ), ONCOCYTE CORP (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), SIENTRA INC (NASDAQ), CONFORMIS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), YESTAR HEALTH (HKEx), CVRX INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), PROFOUND MED CORP (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), QUOTIENT LTD (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), AROA BIOSURGERY LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), PW MEDTECH (HKEx), DARIOHEALTH CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), INVACARE CORP (NYSE), TELA BIO INC (NASDAQ), INTRICOM CORP (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), UGHealthcare (SGX), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), Medtecs Intl (SGX), NEURONETICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SOMNOMED LIMITED (ASX), REPRO MEDSYSTEMS INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), CYCLOPHARM LIMITED (ASX), IMPEDIMED LIMITED (ASX), ALPHA PRO TECH (NYSE American), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), FONAR CORP (NASDAQ), IRIDEX CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), KELFRED (HKEx), ELECTROMED INC (NYSE American), OPTISCAN IMAGING (ASX), BIOLASE INC (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), MICRO-X LTD (ASX), CHECK-CAP LTD (NASDAQ), NEPHROS INC (NASDAQ), CELSION CORPORATION (NASDAQ), SDI LTD (ASX), VINCENT MED (HKEx), HANCOCK JAFFE LABORATORIES INC (NASDAQ), LENSAR INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), VOLITIONRX LIMITED (NYSE American), AVINGER INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), SOLENO THERAPEUTICS INC (NASDAQ), IMMUCELL CORP (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ELECTROCORE INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), PREDICTIVE ONCOLOGY INC (NASDAQ), APPLIED UV INC (NASDAQ), NEUROMETRIX INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), BIOMERICA INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), COMPUMEDICS (ASX), YUNNAN ENERGY (HKEx), AETHLON MEDICAL INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), NEOVASC INC (NASDAQ), DIMERIX LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), DAXOR CORP (NYSE American), NOVA EYE MEDICAL LIMITED (ASX), CARDIEX LTD (ASX), RESPIRI LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), INSPIREMD INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), Yunnan Energy (SGX), TENAX THERAPEUTICS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), SINTX TECHNOLOGIES INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), PLUS THERAPEUTICS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), NUWELLIS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), ADHERIUM LIMITED (ASX), Biolidics (SGX), VIVEVE MEDICAL INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), DYNATRONICS CORP (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE American), XTANT MEDICAL HLDGS INC (NYSE American), OVENTUS MEDICAL LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), LIFE HEALTHCARE (HKEx), CYANOTECH CORP (NASDAQ), METALICITY LIMITED (ASX), OSPREY MEDICAL INC NPV DFD 23/09/21(EX-SPLIT) (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.010
+0.16 %
10 Days --0.520
-7.51 %
20 Days --0.660
-9.35 %
Medium Term Return 3 Months --2.040
-24.17 %
6 Months 0.177-3.290
-32.13 %
1 Year 0.333-7.760
-52.45 %
Long Term Return 2 Years 0.409+1.140
+29.45 %
3 Years 0.472-0.250
+3.34 %
5 Years 0.674+4.100
+207.57 %
Annualised Return Annualised --
+25.20 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.140 - 19.240 Change From 1 Year Low +0.260 % Change From 1 Year Low (%) +4.23
Change From 1 Year High -12.840 % Change From 1 Year High (%) -66.74
2 Years Range 5.080 - 21.160 Change From 2 Years Low +1.320 % Change From 2 Years Low (%) +25.98
Change From 2 Years High -14.760 % Change From 2 Years High (%) -69.75
5 Years Range 2.265 - 21.160 Change From 5 Years Low +4.135 % Change From 5 Years Low (%) +182.56
Change From 5 Years High -14.760 % Change From 5 Years High (%) -69.75
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Established in 1988, Hartalega began with this VISION to produce gloves that protect what matters most, LIFE.



From a humble beginning of a One-Line-Operation, Hartalega has experienced tremendous growth and evolved into a sizeable company of 43 Production Lines, with a capacity to produce over 8 billion gloves annually.



Since inception, every phase of our operation has been dedicated to a Tradition of Excellence.


IPO Performance

Listing Date 17 Apr 2008 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (MYR) 1.800 First Day Close (MYR) 1.910 First Week Close (MYR) 1.790
Current vs IPO Price (%) +255.56 First Day Gain (%) +6.11 First Week Gain (%) -0.56

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2021 Mar 2021 Part 1(2.90 MB)
Annual Report 2020 Mar 2020 Part 1(1.97 MB)
Annual Report 2019 Mar 2019 Part 1(2.69 MB)
Part 2(1.14 MB)
Annual Report 2018 Mar 2018 Part 1(2.47 MB)
Part 2(2.71 MB)
Part 3(0.68 MB)
Annual Report 2017 Mar 2017
Annual Report 2016 Mar 2016 Part 1(2.89 MB)
Part 2(2.90 MB)
Annual Report 2015 Mar 2015 Part 1(2.99 MB)
Annual Report 2014 Mar 2014 Part 1(2.06 MB)
Annual Report 2013 Mar 2013 Part 1(2.10 MB)
Annual Report 2012 Mar 2012 Part 1(2.28 MB)
Part 2(2.23 MB)
Annual Report 2011 Mar 2011 Part 1(0.12 MB)
Part 2(3.08 MB)
Part 3(2.85 MB)
Annual Report 2010 Mar 2010 Part 1(2.72 MB)
Annual Report 2009 Mar 2009 Part 1(2.24 MB)
Part 2(0.04 MB)
Annual Report 2008 Mar 2008 Part 1(0.85 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
17 Sep 2021 6.320 6.580 6.210 6.400 16,705,600 6.3894
15 Sep 2021 6.290 6.300 6.170 6.250 4,211,500 6.2377
14 Sep 2021 6.300 6.330 6.140 6.320 7,730,500 6.2146
13 Sep 2021 6.390 6.390 6.210 6.300 5,189,500 6.2597
10 Sep 2021 6.460 6.660 6.300 6.390 9,984,600 6.4223
09 Sep 2021 6.680 6.750 6.410 6.420 11,051,700 6.5013
08 Sep 2021 6.900 6.900 6.670 6.680 12,349,200 6.7093
07 Sep 2021 6.920 6.950 6.860 6.910 4,326,500 6.8997
06 Sep 2021 6.950 6.970 6.880 6.910 4,817,000 6.9019
03 Sep 2021 7.100 7.100 6.870 6.920 7,954,000 6.9331
02 Sep 2021 7.130 7.170 7.040 7.080 3,763,600 7.0760
01 Sep 2021 7.450 7.450 7.120 7.120 7,112,600 7.1950
30 Aug 2021 7.220 7.380 7.120 7.380 6,949,600 7.2926
27 Aug 2021 7.050 7.250 7.030 7.250 4,147,000 7.1482
26 Aug 2021 7.130 7.200 6.970 7.050 3,756,800 7.0627
25 Aug 2021 7.070 7.220 7.020 7.140 2,918,500 7.1186
24 Aug 2021 6.980 7.070 6.940 7.070 1,751,700 7.0083
23 Aug 2021 7.070 7.090 6.920 6.960 2,953,800 6.9623
20 Aug 2021 7.110 7.150 7.020 7.060 2,718,900 7.0907
19 Aug 2021 7.180 7.210 7.020 7.060 2,771,400 7.0813
18 Aug 2021 7.070 7.290 7.030 7.210 4,711,000 7.1723
17 Aug 2021 6.870 7.090 6.860 7.070 3,993,000 7.0419
Summary
Current 2 Weeks
(03 Sep 2021 to 17 Sep 2021)
7.100 7.100 6.140 6.400 84,320,100 -
Previous 2 Weeks
(19 Aug 2021 to 02 Sep 2021)
7.180 7.210 6.140 7.080 38,843,900 -
4 Weeks from
(21 Jul 2021 to 18 Aug 2021)
7.620 7.920 6.140 7.210 121,261,600 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.